Omega Genetik
All Episodes

ELSA-seq and Methylation-Based Detection

24.10.2026 16 min

The engine of OverC®: the technology stage.

The audio for this episode is coming soon.

This episode may have been prepared with AI assistance; it may contain gaps or phrasing errors. It is for general information only and does not constitute medical advice. For your health decisions, please consult your physician or the Omega Genetik center.

About the Episode

ELSA-seq is a technology platform that builds stable libraries from very low amounts of cfDNA and profiles methylation status at single-base resolution. This episode covers ELSA-seq, the machine-learning-based BRMERMAID® algorithm, the 16-step quality-controlled analysis flow, and how the cancer signal comprehensive score (threshold 0.5) is interpreted.

The scientific foundation of the technology, published in Nature Biomedical Engineering, is also covered.

#overc #teknoloji

Rx-only — prescription screening test. Galleri® is not a diagnostic test. A positive result does not mean a cancer diagnosis; a negative result does not rule out cancer. The test does not replace the routine cancer screenings recommended by your physician. Galleri® does not detect all cancers.

Get Information